Détail de l'auteur
Documents disponibles écrits par cet auteur (11)
Ajouter le résultat à ma sélection Faire une suggestion Affiner la recherche
Article
LUNT (Mark) : GBR. Arthritis Research Uk Epidemiology Unit. School of Translational Medicine. University of Manchester. Manchester. ; Jerry AVORN ; Robert-J GLYNN ; ROTHMAN (Kenneth-J) : USA. Rti Health Solutions. Research Triangle Park. North Carolina. ; STURMER (Til) : USA. Department of Epidemiology. Gillings School of Global Public Health. University of North Carolina at Chapel Hill. Chapel Hill. NC. |[BDSP. Notice produite par INIST-CNRS R0x7FEnC. Diffusion soumise à autorisation]. Propensity score calibration (PSC) can be used to adjust for unmeasured confounders using a cross-sectional validation study that lacks information on the disease[...]
Article
BROOKHART (Malan) : USA. Department of Epidemiology. Unc Gillings School of Global Public Health. University of North Carolina at Chapel Hill. Chapel Hill. NC. ; Jerry AVORN ; BRADBURY (Brian-D) : USA. Department of Biostatistics and Epidemiology. Amgen. Inc. Thousand Oaks. CA. ; Sebastian SCHNEEWEISS ; WINKELMAYER (Wolfgang-C) : USA. Division of Nephrology. Department of Medicine. Stanford University School of Medicine. Palo Alto. CA. ; Division of Pharmacoepidemiology and Pharmacoeconomics. Department of Medicine. Brigham and Women's Hospital and Harvard Medical School. Boston. MA. USA |[BDSP. Notice produite par INIST-CNRS 9n99R0xm. Diffusion soumise à autorisation]. Hemodialysis patients who live at high altitude use less exogenous erythropoietin but achieve higher hematocrit levels than those living at a lower altitude. The [...]
Article
STURMER (Til) : USA. Department of Epidemiology. Gillings School of Global Public Health. University of North Carolina at Chapel Hill. Chapel Hill. NC. ; Jerry AVORN ; GLYNN (Robert-J) : USA. Department of Biostatistics. Harvard School of Public Health. Boston. MA. ; ROTHMAN (Kenneth-J) : USA. Rti Health Solutions. Research Triangle Park. NC. ; Division of Pharmacoepidemiology and Pharmacoeconomics. Brigham and Women's Hospital. Harvard Medical School. Boston. MA. USA |[BDSP. Notice produite par INIST-CNRS plr9R0xq. Diffusion soumise à autorisation]. Frailty, a poorly measured confounder in older patients, can promote treatment in some situations and discourage it in others. This can create unmeasured confound[...]
Article
Malan BROOKHART ; Jerry AVORN ; Suzanne-M CADARETTE ; DORMUTH (Colin) : CAN. Therapeutics Initiative. University of British Columbia. Vancouver. BC. ; Amanda-R PATRICK ; William SHRANK ; Daniel-H SOLOMON ; Brigham and Women's Hospital. Harvard Medical School. Department of Medicine. Division of Pharmacoepidemiology and Pharmacoeconomics. Boston. MA. USA |[BDSP. Notice produite par INIST-CNRS R0x6XZpC. Diffusion soumise à autorisation]. Patients who adhere to preventive therapies may be more likely to engage in a broad spectrum of behaviors consistent with a healthy lifestyle. Because many of the[...]
Article
Til STURMER ; Jerry AVORN ; GLYNN (Robert-J) : USA. Department of Biostatistics. Harvard School of Public Health. Boston. MA. ; ROTHMAN (Kenneth-J) : USA. Department of Epidemiology. Boston University School of Public Health. Boston. MA. ; SCHNEEWEISS (Sebastian) : USA. Department of Epidemiology. Harvard School of Public Health. Boston. MA. |[BDSP. Notice produite par INIST-CNRS 1txR0xAb. Diffusion soumise à autorisation]. Confounding can be a major source of bias in nonexperimental research. The authors recently introduced propensity score calibration (PSC), which combines propensi[...]
Article
Malan BROOKHART ; Jerry AVORN ; Robert-J GLYNN ; ROTHMAN (Kenneth-J) : USA. Departments of Epidemiology and Medicine. Boston University Medical Center. Boston. MA. ; Sebastian SCHNEEWEISS ; Til STURMER ; Brigham and Women's Hospital and Harvard Medical School. Department of Medicine. Division of Pharmacoepidemiology and Pharmacoeconomics. Boston. MA. USA |[BDSP. Notice produite par INIST-CNRS Zc5R0xB1. Diffusion soumise à autorisation]. Despite the growing popularity of propensity score (PS) methods in epidemiology, relatively little has been written in the epidemiologic literature about the prob[...]
Article
Til STURMER ; Jerry AVORN ; GLYNN (Robert-J) : USA. Department of Biostatistics. Harvard School of Public Health. Boston. MA. ; SCHNEEWEISS (Sebastian) : USA. Department of Epidemiology. Harvard School of Public Health. Boston. MA. ; Brigham and Women's Hospital. Harvard Medical School. Division of Pharmacoepidemiology and Pharmacoeconomics. Boston. MA. USA ; Brigham and Women's Hospital. Harvard Medical School. Division of Preventive Medicine. Boston. MA. USA |[BDSP. Notice produite par INIST-CNRS UR0xYINm. Diffusion soumise à autorisation]. Often, data on important confounders are not available in cohort studies. Sensitivity analyses based on the relation of single, but not multiple, unmeasured confo[...]
Article
Til STURMER ; Jerry AVORN ; Malan BROOKHART ; Robert-J GLYNN ; Kenneth-J ROTHMAN ; Sebastian SCHNEEWEISS ; Harvard Medical School. Brigham and Women's Hospital. Division of Pharmacoepidemiology and Pharmacoeconomics. Boston. MA. USA |[BDSP. Notice produite par INIST-CNRS 291R0xtx. Diffusion soumise à autorisation]. Little is known about optimal application and behavior of exposure propensity scores (EPS) in small studies. In a cohort of 103,133 elderly Medicaid beneficiaries[...]
Article
Charles-A MORRIS ; Jerry AVORN ; Division of Pharmacoepidemiology and Pharmacoeconomics. Department of Medicine. Brigham and Women's Hospital. Harvard Medical School. Boston. MA. USA |[BDSP. Notice produite par INIST-CNRS R0xD5CWJ. Diffusion soumise à autorisation]. Context Passage of the Dietary Supplement Health and Education Act in 1994 restricted the Food and Drug Administration's control over dietary supplements, leading[...]
Article
Joshua-S BENNER ; Jerry AVORN ; Robert-J GLYNN ; Helen MOGUN ; Peter-J NEUMANN ; Milton-C WEINSTEIN ; Center for Risk Analysis. Harvard School of Public Health. Boston. MA. USA ; Division of Pharmacoepidemiology & Pharmacoeconomics. Department of Medicine. Brigham and Women's Hospital and Harvard Medical School. Boston Mass. EGY |[BDSP. Notice produite par INIST-CNRS R0xy55iB. Diffusion soumise à autorisation]. Context Knowledge of long-term persistence with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy is limited because previous studies hav[...]
Article
Sebastian SCHNEEWEISS ; Jerry AVORN ; Robert-J GLYNN ; Malcolm MACLURE ; John-D SEEGER ; Philip-S WANG ; Division of Pharmacoepidemiology and Pharmacoeconomics. Brigham and Women's Hospital and Harvard Medical School. Boston. MA. USA |[BDSP. Notice produite par INIST-CNRS bh2GR0xl. Diffusion soumise à autorisation]. Comorbidity is an important confounder in epidemiologic studies. The authors compared the predictive performance of comorbidity scores for use in epidemiologic re[...]
